Skip to main content

Table 4 Percentage of drug costs classified by ATC

From: Cost-effectiveness analysis of the introduction of S-1 therapy for first-line metastatic breast cancer treatment in Japan: results from the randomized phase III SELECT BC trial

ATC code

ATC name

Taxane

S-1

L01

Antineoplastic agents

66%

59%

M05

Drugs for treatment of bone diseases

10%

16%

N02

Analgesics

9%

3%

L02

Endocrine therapy

3%

9%

A04

Antiemetics and antinauseants

3%

2%

V08

Contrast media

2%

2%

V09

Diagnostic raidopharmaceutical

1%

1%

A02

Drugs for acid and related disorders

1%

1%

 

Others

5%

7%